Filing Details
- Accession Number:
- 0001189727-15-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-10 19:05:47
- Reporting Period:
- 2015-06-10
- Filing Date:
- 2015-06-10
- Accepted Time:
- 2015-06-10 19:05:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189727 | D Alison Burcar | 951 Calle Amanecer San Clemente CA 92673 | Vice President And Gen'l Mgr. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-10 | 417 | $43.12 | 417 | No | 4 | X | Direct | |
Common Stock | Acquisiton | 2015-06-10 | 172 | $43.62 | 589 | No | 4 | X | Direct | |
Common Stock | Disposition | 2015-06-10 | 417 | $97.00 | 172 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-10 | 172 | $97.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-06-10 | 417 | $0.00 | 417 | $43.12 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-06-10 | 172 | $0.00 | 172 | $43.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-02-02 | No | 4 | X | Direct | |
1,495 | 2021-07-20 | No | 4 | X | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 7, 2015.
- Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
- Transaction is the exercise of a derivative security; see Column 2.